Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
Feature|Articles|March 4, 2026
GLP-1s reshape obesity care as use rises, persistence and cost remain key questions
Author(s)Briana Contreras
As World Obesity Day spotlights rising obesity rates, GLP-1s reshape treatment and coverage debates, with persistence, affordability and long-term value driving payer decisions.
Advertisement
Advertisement
Most days, including World Obesity Day, the conversations around weight management have been much different than they were just a few years ago. Obesity rates remain high, but new data suggests injectable glucagon-like peptide-1 (GLP-1) drugs are beginning to influence both clinical practice and utilization trends across the healthcare system.
Related to this article
Rex Hoffman, M.D., MBA, of Providence Holy Cross walks through a CMO’s day in a hospital that often runs 85% to 100% full, from safety huddles to discharges.
On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found.
Research findings presented at CHEST meeting show COPD hospital readmission drops with discharge checklists and navigation. Other research suggests targeting readmission prevention efforts on patents discharged to post-acute facilities.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.
New data from Sutter Health suggest the real gap in GLP-1 access is physician awareness, not insurance coverage — and fixing it closed outcome disparities across every racial and ethnic group.
Research findings presented at the CHEST meeting show that false positives may make patients more adherent to screening. Qualitative research shows that patients want more explanation and results communicated verbally.
Advertisement
Advertisement